Evolus Goodwill and Intangible Assets 2016-2023 | EOLS
Evolus goodwill and intangible assets from 2016 to 2023. Goodwill and intangible assets can be defined as the sum of all intangible asset fields
| Evolus Annual Goodwill and Intangible Assets (Millions of US $) |
|
|---|---|
| 2023 | $68 |
| 2022 | $70 |
| 2021 | $72 |
| 2020 | $77 |
| 2019 | $81 |
| 2018 | $77 |
| 2017 | $77 |
| 2016 | $77 |
| 2015 | $77 |
| Evolus Quarterly Goodwill and Intangible Assets (Millions of US $) |
|
|---|---|
| 2023-12-31 | $68 |
| 2023-09-30 | $68 |
| 2023-06-30 | $68 |
| 2023-03-31 | $69 |
| 2022-12-31 | $70 |
| 2022-09-30 | $70 |
| 2022-06-30 | $71 |
| 2022-03-31 | $71 |
| 2021-12-31 | $72 |
| 2021-09-30 | $73 |
| 2021-06-30 | $74 |
| 2021-03-31 | $75 |
| 2020-12-31 | $77 |
| 2020-09-30 | $78 |
| 2020-06-30 | $79 |
| 2020-03-31 | $80 |
| 2019-12-31 | $81 |
| 2019-09-30 | $81 |
| 2019-06-30 | $80 |
| 2019-03-31 | $80 |
| 2018-12-31 | $77 |
| 2018-09-30 | $77 |
| 2018-06-30 | $77 |
| 2018-03-31 | $77 |
| 2017-12-31 | $77 |
| 2017-09-30 | $0 |
| 2017-06-30 | $0 |
| 2017-03-31 | $0 |
| 2016-12-31 | $77 |
| 2015-12-31 | $77 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.689B | $0.202B |
| Evolus, Inc. is a medical aesthetics company. It focuses on providing physicians and patients in aesthetic procedures and treatments. The company focuses on the self-pay aesthetic market and its lead product candidate, DWP-450, is an injectable 900 kDa purified botulinum toxin type A complex. Evolus, Inc. is based in Irvine, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $188.944B | 24.52 |
| Stryker (SYK) | United States | $129.029B | 31.99 |
| Medtronic (MDT) | Ireland | $106.531B | 15.08 |
| Boston Scientific (BSX) | United States | $98.941B | 32.90 |
| EssilorLuxottica (ESLOY) | France | $97.450B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $43.229B | 0.00 |
| Haleon (HLN) | United Kingdom | $36.803B | 28.79 |
| ResMed (RMD) | United States | $27.225B | 27.22 |
| Zimmer Biomet Holdings (ZBH) | United States | $25.477B | 16.40 |
| Terumo (TRUMY) | Japan | $24.641B | 34.80 |
| Baxter (BAX) | United States | $20.333B | 14.83 |
| Koninklijke Philips (PHG) | Netherlands | $18.954B | 15.12 |
| Insulet (PODD) | United States | $12.180B | 63.95 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $10.404B | 0.00 |
| Demant (WILYY) | Denmark | $10.167B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.567B | 25.52 |
| BellRing Brands (BRBR) | United States | $7.140B | 38.39 |
| Haemonetics (HAE) | United States | $4.311B | 22.05 |
| Lantheus Holdings (LNTH) | United States | $4.130B | 10.66 |
| Perrigo (PRGO) | Ireland | $4.083B | 11.68 |
| GN Store Nord (GNNDY) | Denmark | $3.675B | 23.80 |
| Prestige Consumer Healthcare (PBH) | United States | $3.383B | 15.99 |
| Envista Holdings (NVST) | United States | $3.289B | 12.51 |
| QuidelOrtho (QDEL) | United States | $2.772B | 10.06 |
| Green Thumb Industries (GTBIF) | United States | $2.630B | 83.33 |
| Neogen (NEOG) | United States | $2.601B | 25.02 |
| ICU Medical (ICUI) | United States | $2.366B | 17.66 |
| TG Therapeutics (TGTX) | United States | $2.173B | 703.50 |
| Maravai LifeSciences Holdings (MRVI) | United States | $2.039B | 0.00 |
| Owens & Minor (OMI) | United States | $1.914B | 18.38 |
| Verano Holdings (VRNOF) | United States | $1.710B | 0.00 |
| Agios Pharmaceuticals (AGIO) | United States | $1.644B | 0.00 |
| National Vision Holdings (EYE) | United States | $1.505B | 46.88 |
| InMode (INMD) | Israel | $1.486B | 7.69 |
| LeMaitre Vascular (LMAT) | United States | $1.437B | 47.74 |
| AdaptHealth (AHCO) | United States | $1.313B | 9.88 |
| Warby Parker (WRBY) | United States | $1.282B | 0.00 |
| AtriCure (ATRC) | United States | $1.108B | 0.00 |
| MacroGenics (MGNX) | United States | $1.060B | 0.00 |
| BioLife Solutions (BLFS) | United States | $0.710B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.706B | 15.26 |
| Cresco Labs (CRLBF) | United States | $0.691B | 0.00 |
| Quanterix (QTRX) | United States | $0.653B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.636B | 0.00 |
| Valneva SE (VALN) | France | $0.590B | 0.00 |
| Jin Medical (ZJYL) | China | $0.541B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.535B | 11.59 |
| TerrAscend (TSNDF) | Canada | $0.524B | 0.00 |
| PetIQ (PETQ) | United States | $0.476B | 17.78 |
| Biote (BTMD) | United States | $0.439B | 4.18 |
| ZimVie (ZIMV) | United States | $0.428B | 26.23 |
| OraSure Technologies (OSUR) | United States | $0.414B | 6.85 |
| Zynex (ZYXI) | United States | $0.385B | 44.30 |
| Surmodics (SRDX) | United States | $0.376B | 40.65 |
| Aurora Cannabis (ACB) | Canada | $0.343B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.315B | 31.31 |
| Cerus (CERS) | United States | $0.314B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.278B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.250B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.245B | 14.95 |
| Veru (VERU) | United States | $0.224B | 0.00 |
| Omeros (OMER) | United States | $0.196B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.194B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.185B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.182B | 0.00 |
| High Tide (HITI) | Canada | $0.178B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.161B | 0.00 |
| Eagleford Energy (GRUSF) | United States | $0.135B | 68.00 |
| FitLife Brands (FTLF) | United States | $0.134B | 21.52 |
| Jushi Holdings (JUSHF) | United States | $0.132B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.114B | 0.00 |
| InterCure (INCR) | Israel | $0.112B | 18.85 |
| Cellectar Biosciences (CLRB) | United States | $0.107B | 0.00 |
| Fonar (FONR) | United States | $0.106B | 9.15 |
| Safety Shot (SHOT) | United States | $0.098B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.098B | 0.00 |
| MariMed (MRMD) | United States | $0.098B | 0.00 |
| Brainsway (BWAY) | Israel | $0.088B | 0.00 |
| Chimerix (CMRX) | United States | $0.082B | 0.00 |
| Zevia PBC (ZVIA) | United States | $0.070B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.068B | 4.41 |
| United Health Products (UEEC) | United States | $0.052B | 0.00 |
| Apyx Medical (APYX) | United States | $0.048B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.047B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.045B | 0.00 |
| Bright Green (BGXX) | United States | $0.041B | 0.00 |
| ImmuCell (ICCC) | United States | $0.039B | 0.00 |
| United-Guardian (UG) | United States | $0.035B | 13.75 |
| Modular Medical (MODD) | United States | $0.034B | 0.00 |
| Exagen (XGN) | United States | $0.025B | 0.00 |
| Nephros (NEPH) | United States | $0.021B | 0.00 |
| FSD PHARMA (HUGE) | Canada | $0.021B | 0.00 |
| Flora Growth (FLGC) | United States | $0.019B | 0.00 |
| Agape ATP (ATPC) | $0.018B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.017B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.015B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.011B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.010B | 71.73 |
| ProSomnus (OSA) | United States | $0.009B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.008B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.007B | 0.00 |
| Sharps Technology (STSS) | United States | $0.005B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
| Senestech (SNES) | United States | $0.004B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.004B | 0.00 |
| Lucy Scientific Discovery (LSDI) | Canada | $0.002B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
| Smart For Life (SMFL) | United States | $0.000B | 0.00 |
| Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |